Qiming U.S. Ventures Management, LLC
CIK
1909617
Location
Bellevue, WA
Portfolio Value
Micro
$20,161,720
Diversification
Highly concentrated
Filing Date
Global Rank
#7,296
/ 7,986
▲ 287
· as of Sep 2025
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-61.4%
Period ended 9 months ago
Filed Nov 10, 2025 · 8mo
8 quarters · since Dec 2023
Clone Performance
Feb 2024–Jul 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-71.3%
SPY
+54.1%
Annualised alpha
-60.4%
Max drawdown
−92.8%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
3 positions · as of Sep 30, 2025 · Δ vs Jun 30, 2025Top Position
87.4%
+36.5 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
7,767
Highly concentrated+3,105
Portfolio Trend
8 quarters · across all stocks
Sector Breakdown
As of Sep 30, 2025| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $20,161,720 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
3 positions ·
$20,161,720 total
· as of Sep 30, 2025
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| KRRO |
Korro Bio, Inc.
Healthcare
|
Held | 368,085 | $17,627,590 | 87.43% | |
| JSPR |
Jasper Therapeutics, Inc.
Healthcare
|
Held | 928,964 | $2,210,934 | 10.97% | |
| KZR |
Kezar Life Sciences, Inc.
Healthcare
|
Held | 82,871 | $323,196 | 1.60% |